EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies

Silvana Di Palma, Panagiotis Koliou, Alex Simonovic, Daniela Costa, Catherine Faulkes, Brenda Kobutungi, Felicity Paterson, Jonathan David Horsnell, Farrokh Pakzad, Tracey Irvine, Polly Partlett, Elizabeth Clayton und 1 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Silvana Di Palma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Pathology, Berkshire & Surrey Pathology Services, The Royal Surrey Hospital NHS Foundation Trust, University of Surrey, Egerto…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: APIS BC Subtyping group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The APIS Breast Cancer Subtyping Kit is an mRNA-based assessment of the seven parameters including three biomarkers routinely assessed in all the newly diagnosed breast cancers (BC), oestrogen receptor (ER), progesterone receptor (PR) and HER-2 and an additional four genes that create a novel proliferation signature, MKI67, PCNA, CCNA2 and KIF23. Taken together, the data are used to produce a molecular subtype for every sample. The kit was evaluated against the current standard protocol of immunohistochemistry (IHC) and/or in situ hybridisation (ISH) in breast cancer patients. The data were presented at the weekly breast multidisciplinary team (MDT) meeting. A total of 98 consecutive cases of pre-operative breast cancer core biopsies and two core biopsies of nodal metastases yielding 100 cases were assessed. IHC and APIS results were available for 100 and 99 cases. ER was concordant in 97% cases, PR was concordant in 89% and HER-2 results were concordant with IHC/ISH in 100% of the cases. Ki-67 IHC was discordant in 3% of cases when compared with MK167 alone but discordant in 24% when compared with the four-gene proliferation signature. In conclusion, our study indicates that the APIS Breast Cancer Subtyping Kit is highly concordant when compared to the results produced for ER/PR/HER-2 by IHC and/or ISH. The assay could play a role in the routine assessment of newly diagnosed breast cancer (BC) specimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansBeesAnimalsFemaleErb-b2 Receptor Tyrosine KinasesBreastReceptors, EstrogenImmunohistochemistryBiopsyBiomarkers, TumorReceptors, Progesterone

Stichwörter der Autor:innen

APIS mRNA molecular assessmentERHER-2Ki-67PRbreast cancerimmunohistochemistry

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenBiomarkers, TumorReceptors, Progesterone

Autor:innen und Institutionen

  • Department of Cellular Pathology, Berkshire & Surrey Pathology Services, The Royal Surrey Hospital NHS Foundation Trust, University of Surrey, Egerton Road, Guildford GU2 7XX, UK.
  • Department of Oncology, The Royal Surrey Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.
  • Molecular Diagnostics, Berkshire & Surrey Pathology Services, The Royal Surrey Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.
  • Breast Unit, The Royal Surrey Hospital NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, UK.

Förderung

  • APIS BC Subtyping group

Zitieren

APA

Di Palma, S., Koliou, P., Simonovic, A., Costa, D., Faulkes, C., Kobutungi, B., Paterson, F., Horsnell, J. D., Pakzad, F., Irvine, T., Partlett, P., Clayton, E., & Collins, N. (2024). Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052616

Vancouver

Di Palma S, Koliou P, Simonovic A, Costa D, Faulkes C, Kobutungi B, et al. Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052616

BibTeX
@article{DiPalma2024,
  author = {Di Palma, Silvana and Koliou, Panagiotis and Simonovic, Alex and Costa, Daniela and Faulkes, Catherine and Kobutungi, Brenda and Paterson, Felicity and Horsnell, Jonathan David and Pakzad, Farrokh and Irvine, Tracey and Partlett, Polly and Clayton, Elizabeth and Collins, Nadine},
  title = {Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052616}
}
Kostenlos starten →